학술논문
Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis
Document Type
Article
Author
Source
In European Journal of Pharmacology 5 March 2024 966
Subject
Language
ISSN
0014-2999